E. Vega

823 total citations
12 papers, 656 citations indexed

About

E. Vega is a scholar working on Pharmaceutical Science, Biomaterials and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E. Vega has authored 12 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Biomaterials and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E. Vega's work include Advanced Drug Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Ocular Surface and Contact Lens (5 papers). E. Vega is often cited by papers focused on Advanced Drug Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Ocular Surface and Contact Lens (5 papers). E. Vega collaborates with scholars based in Spain, Ireland and Portugal. E. Vega's co-authors include María L. García, M.A. Egea, Marta Espina, Ana Cristina Calpena, Carla M. Lopes, Eliana B. Souto, Joana Araújo, Oriol T. Valls, Alain Chauvet and Isabel Haro and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Colloids and Surfaces B Biointerfaces and International Journal of Nanomedicine.

In The Last Decade

E. Vega

11 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Vega Spain 8 413 193 184 147 71 12 656
Yanzhong Chen China 14 321 0.8× 113 0.6× 215 1.2× 128 0.9× 61 0.9× 28 587
Gautam Behl United States 15 204 0.5× 210 1.1× 125 0.7× 154 1.0× 136 1.9× 19 588
Martin Hoffer Austria 10 411 1.0× 247 1.3× 89 0.5× 131 0.9× 63 0.9× 10 697
Gyan Prakash Mishra United States 12 172 0.4× 179 0.9× 136 0.7× 169 1.1× 87 1.2× 21 558
Nurşen Ünlü Türkiye 14 319 0.8× 115 0.6× 232 1.3× 145 1.0× 60 0.8× 16 625
Pradeep K. Karla United States 11 288 0.7× 107 0.6× 239 1.3× 153 1.0× 45 0.6× 15 674
M. Merodio Spain 7 169 0.4× 189 1.0× 56 0.3× 214 1.5× 71 1.0× 8 489
Zeinab Fathalla Egypt 9 271 0.7× 74 0.4× 126 0.7× 82 0.6× 41 0.6× 21 472
Peter W. J. Morrison United Kingdom 9 419 1.0× 112 0.6× 370 2.0× 167 1.1× 52 0.7× 9 767
Viral Tamboli United States 7 144 0.3× 119 0.6× 120 0.7× 117 0.8× 55 0.8× 8 401

Countries citing papers authored by E. Vega

Since Specialization
Citations

This map shows the geographic impact of E. Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Vega more than expected).

Fields of papers citing papers by E. Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Vega. The network helps show where E. Vega may publish in the future.

Co-authorship network of co-authors of E. Vega

This figure shows the co-authorship network connecting the top 25 collaborators of E. Vega. A scholar is included among the top collaborators of E. Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Vega. E. Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Vega, E., et al.. (2024). Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy. Expert Opinion on Drug Delivery. 21(9). 1385–1394. 1 indexed citations
3.
Esteruelas, Gerard, A. Ortiz, E. Vega, et al.. (2023). Novel customized age-dependent corneal membranes and interactions with biodegradable nanoparticles loaded with dexibuprofen. Colloids and Surfaces B Biointerfaces. 228. 113394–113394. 2 indexed citations
4.
García, María L., et al.. (2015). Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. International Journal of Nanomedicine. 10. 609–609. 96 indexed citations
5.
Vega, E., María Antonia Egea, Marı́a Luisa Garduño-Ramı́rez, et al.. (2013). Flurbiprofen PLGA-PEG nanospheres: Role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy. Colloids and Surfaces B Biointerfaces. 110. 339–346. 49 indexed citations
7.
Araújo, Joana, E. Vega, Carla M. Lopes, et al.. (2009). Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids and Surfaces B Biointerfaces. 72(1). 48–56. 127 indexed citations
8.
Valls, Rosa M., et al.. (2008). Transcorneal Permeation in a Corneal Device of Non-Steroidal Anti-Inflammatory Drugs in Drug Delivery Systems. PubMed. 2(1). 66–71. 33 indexed citations
9.
Vega, E., et al.. (2008). Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nuclear Medicine Communications. 29(2). 166–172. 48 indexed citations
10.
Vega, E., et al.. (2008). PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions. Journal of Pharmaceutical Sciences. 97(12). 5306–5317. 115 indexed citations
11.
Vega, E., M.A. Egea, Oriol T. Valls, Marta Espina, & María L. García. (2006). Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration. Journal of Pharmaceutical Sciences. 95(11). 2393–2405. 102 indexed citations
12.
Vega, E., et al.. (1975). Estudios sobre la juventud marginal latinoamericana. Revista española de la opinión pública. 184–184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026